Two recently developed two-step, or "back-titration" assay kits for free thyroxine (FT4)-one based on a europium-labeled derivative of T4, the other on conventional radiolabeled T4-were compared with both symmetrical dialysis and an indirect FT4 radioimmunoassay. Discrepancies between the two-step and the other two methods were observed, particularly in samples that had very low to zero thyroxine-bindingglobulin (TBG) content. In those instances the two-step methods gave values almosttwice as high as the other methods. This effect could be largely reversed in one of the two-step assays and completely reversed in the other by performing the first incubation step at 37 #{176}C rather than at room temperature, as pre- which has led to serious criticism regarding assay validity (1, 4) .
(1), equilibrium dialysis and ultrafiltration, followed by highly sensitive RIA of thyroxine (T4) in the dialysate or ultrafiltrate, are considered as the most accurate methods for determination of free thyroxine (FT4).2 Despite the fact that recently an equilibrium dialysisfRLA has become commercially available (2), these techniques are often considered too cumbersome for routine use. In the last decade, commercial methods for FT4 estimations emerged, the most popular of which were based on the labeled analog (3) principle. This principle is theoretically valid, but until now noT4 analogs have been found that meet the specifications dictated by the theory- which has led to serious criticism regarding assay validity (1, 4) .
Another valid assay principle, often referred to as two-step or back-titration, which does not critically depend on the properties of one crucial reagent, also has been commercially exploited (5), but the analog-based approach has gained greater popularity because of its relative ease of performance and better precision. Recently, some new commercial FT4 kits that are based on the two-step principle were introduced, two of which we tested for assay accuracy in our laboratory.
The first tested was a (time-resolved) fluoroinirnunoassay (FIA), with a europium-labeled T4 derivative as tracer (6) . Later we included in the investigation a second two-step Fr4 assay, this one involving a conventional radioactivity label (6) . We compared these assays with an indirect, nonanalog FT4 radioimmunoassay (7) and with symmetrical dialysis (8) .
Recently, Ekins (1) extensively reviewed the theory of all three methods used in this study. Therefore, the operation principles are only briefly indicated here.
In the indirect RIA the sample with added T4 tracer is incubated in a test tube that is coated with a lowaffinity monoclonal antibody to T4. Consequently, the amount of T4 that binds to the antibody is directly proportional to the FT4 concentration in the sample solution. Thus, the ratio of antibody-bound radioactivity to that in solution reflects the proportion of the sample's T4 that is free, i.e., FT4%. The proportionality factor is solved by assaying a reference standard with known FT4%. The FT4% result is then multiplied by the total T4 concentration as assessed by RIA to obtain the VP4 concentration.
In the first step of a two-step immunoassay for FT4, the sample is also incubated with a specific T4 antibody, but without tracer. Here the antibody has a high affinity so that the extent to which it becomes saturated with T4 depends on the FT4 concentration in solution during this first incubation. A measure of the degree of antibody saturation is obtained during the second phase, in which the sample has been completely removed and tracer has been added. This step often is considered as a backtitration step because the tracer initially binds to the Symmetrical dialysis differs from equilibrium dialysis in many respects, the most important one being that the sample to be analyzed is present on both sides of the dialysis membrane. Tracer, which is initially present on only one side of the membrane, will eventually be equally distributed over both compartments, but the rate at which final equilibrium is approached is a function of the free ligand fraction in the sample. Because of the clear mathematical relationship between the tracer distribution as a function of time and the free ligand fraction, this fraction can be estimated from tracer distribution at any time, by comparison with the tracer distribution obtained by dialysis of a standard with known free ligand fraction.
Preliminary results showed that the two-step assays gave much higher FT4 values in samples from patients with complete thyroxine-binding globulin (TBG) deficiency than either indirect RIA or symmetrical dialysis. Because in both two-step assays the first-step equilibration with antibody takes place at room temperature, whereas the other two assays operate at 37 #{176}C, we investigated whether the temperature at which the crucial first incubation of each assay is performed significantly contributes to this discrepancy. The second step (back-titration) for the FIA was performed at 4#{176}C and for the two-step RIA at room temperature. Both methods showed constancy of VP4 with dilution by at least twofold. Interassay coefficients of variation (CVs) ranged between 5% and 8% and did not differ substantially from the manufacturers' specifications.
Materials and Methods

Materials
The Fr4 assay denoted as indirect RIA (SPAC ET;
Byk-Sangtec, Dietzenbach, FRG), was carried out according to the kit insert with use of an extended calculation method (7) involving the total T4 as measured by the method indicated below. The incubation medium is phosphate-buffered saline (0.15 mol/L NaCl, 0.01 molIL phosphate). Results were expressed in terms of the VP4 fraction in undiluted serum, by assuming proportionality with dilution (10). The VP4 concentration was obtained by multiplying the measured VP4 fraction by the total T4 concentration. For symmetrical dialysis as well as the indirect RIA, the 95% reference range for VP4 in healthy young individuals is 9-16 pmolJL.
Other assays. for the samples with oleate added as an inhibitor. Actual statistical evaluation of differences in temperature effect was performed by comparing the ratios of VP4 at 21 #{176}C to that at 37#{176}C as shown in Table 1 .
The temperature effect was also investigated with the two-step FIA and two-step RIA kits (Figure 3 ) by performing first incubations at 37#{176}C and comparing the results with those obtained with the incubation at room temperature.
Note that, in these assays, the temperature effect that can be observed is always relative to the kit standards.
As in symmetrical dialysis, the zero-TBG samples in the two-step FIA behaved differently from the other samples. The average ratio for 21 #{176}C/37 #{176}C VP4 was 1.50 (SD 0.16), significantly (P <0.01) higher than for the normal-binding samples:
1.06 (SD 0.13). The only other samples showing a tendency towards a temperature effect were the two treated with thimerosal.
In the two-step RIA, these latter two samples seemed to show temperature dependence, although in opposite directions. dialysis could be reversed, we performed the first incubation of the twostep assays at 37 #{176}C. As Figure 4 (left) shows, only for the TBG-deficient samples could the discrepancy between FIA and dialysis be accounted for, at least partially, by the temperature effect. Despite the highly significant relative decrease of VP4 (by a factor 1.5; see above), only two of the zero-TBG samples now were within the 99% confidence limits of the normal-binding sera. The most prominent discrepancies, existing also at room temperature, were those of the kit standards and the samples with oleate addition. For the two-step RIA, all three zero-TBG samples fell within the confidence limits (Figure 4, right) indirect RIA, methods that differ greatly in assay principle. In contrast, the two-step FIA and RIA gave increased VP4 values for TBG-deficient samples. Given that the basic principle of the two-step methodology is perfectly valid, the cause for these discrepant observations had to be one of assay design. Essential to free thyroid hormone assay is the notion that, because of the very-low free-hormone fraction (a few tenths of a percent or less), the concentration of VP4 or free triiodothyronine is theoretically, within certain limits, independent of sample dilution (8, 10). However, this holds only for an ideal dilution medium in which the essential equilibrium constants involved remain unchanged and that does not contain additional hormone-binding substance or hormone-binding-inhibiting (13) substances. In VP4 immunoassays, sample dilution in a medium that contains T4 antibody is inherent to the method. These assays (including the indirect RIA and the twostep assays, but also the labeled analog technique), therefore, include standard samples, and it is implicitly assumed that the effect of the assay medium on VP4 concentration is identical in samples and standards. affinity (3, 14, 15) . However, the fact that inclusion of albumin in the presence of the sample produces the same effect (4) has been largely overlooked, and some manufacturers still add albumin to their incubation buffers while at the same time keeping the amount of antibody to a minimum (6, 16) . The importance of the presence of certain ions, particularly chloride, has also been shown (17,18), as well as the occurrence of differential effects of dilution in chloride-free media (19,20), but apparently this has likewise been overlooked by some manufacturers.
Here the normal-binding samples gave an
In the two-step kits we tested, the absence of a differential effect has also been assumed with regard to the influence of lowering the temperature of the crucial first incubation from 37#{176}C to room temperature.
But this report provides ample evidence that the temperature at which the first incubation is performed affects the VP4 in TBG-deflcient samples differently from the VP4 in samples with TBG. We demonstrated by means of symmetrical dialysis that FT4 in normal-binding sera, when measured at room temperature, averaged 41% of its value at 37 #{176}C, whereas the zero-TBG samples showed a decrease only to 77% when measured at room temperature (Table 1 and Figure 2 ). In the two-step Although we showed that VP4 in most cases was rather low, more accurate estimates may be obtained by using completely T4-free sera. At 37#{176}C, the estimated temperature coefficient for T4-binding with TBG was 6.8% and for binding with TTR + albumin was 2.2% per degree Celsius. With 75% of total T4 bound to TBG, one thus would predict a temperature effect in an average sample of 5.6% per degree Celsius. This is consistent with the temperature coefficient for the average of normal binding samples of 5.3% per degree Celsius estimated by assuming that the van 't Hoff equation may be applied to the joined T4 binding sites in serum. If this also applies to the in vivo situation, an increase in body temperature to 39#{176}C would result in an increase of VP4 by -10%. At this point, we can only speculate about the possible relevance to pathophysiology of body temperature regulation if this is so. Between the zero-TBG and the normal-binding samples, the differential temperature effect is largely the same in either dialysis and the two-step RIA and FIA. However, for other samples, a temperature effect may exist in one assay and be absent in the other (Table 1 and Figures 2 and 3) ; furthermore, some discrepancies between methods appear to be independent of temperature ( Figure 1, a and b vs Figure 4 ). In the FIA, the dilution during the first incubation is 10-fold, and the buffer contains twice the physiological concentration of chloride (200 mniollL) (5). The buffer also contains bovine serum albumin, 5 g/L, i.e., a quantity equal to that of the serum albumin already present, and Tween 40 (5), a potent inhibitor of ligand-protein interactions. Although the net effect of these additions is difficult to predict, it is hardly surprising that discrepancies with results by dialysis remain even when the FIA is performed at 37 #{176}C. The much higher values for the samples with added oleate become plausible if we assume that the detergent Tween inhibits binding of oleate to albumin, thus freeing the fatty acid to inhibit 'F4binding to TBG (23) . No satisfactory explanation can be found for the lower values obtained for the FIA standards in symmetrical dialysis.
In the two-step RIA, sample dilution is 12-fold, and the buffer contains only HEPES (10 mmol/L). Only one normal binding sample and one FIA standard assayed in the RIA at 37 #{176}C gave results different from dialysis (Figure 4, right) , but it is doubtful whether this is of great significance. On the other hand, lowering the temperature affected normal binding samples in the RIA less than it did the standards, whereas in the dialysis the reverse was the case (Table 1 ).
In conclusion, we point out the following #{149} VP4 strongly depends on temperature. Ordinarily, at 21 #{176}C FT4 is only 40% of the VP4 at 37 #{176}C.
#{149} Temperature affects T4 binding to TBG on one hand and to TTR and albumin on the other, but to a significantly different extent. Therefore the effect of a change in temperature on VP4 depends on the distribution of T4 over the different binding proteins. Thus, to answer the question in the title of this study, VP4 is not accurately measurable at room temperature. 3 'The differential effect of temperature on VP4 in samples with and without TBG is observed independently of the assay method used. Discrepancies between two-step assays and dialysis can partially be attributed to the temperature effect. However, buffer composition very probably accounts for the remaining discrepancies. The use of less-unphysiological buffers is recommended.
'The magnitude of the effect of temperature on VP4 in vitro justifies further study of VP4 and free triiodothyronine at pathophysiological temperature ranges, with possible relevance for thyroid hormone action and metabolism at abnormal body temperatures.
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